No Data
No Data
ZHONG JI LS (00767.HK) and Huali Life have established a joint venture to provide longevity health services in China.
On April 1, Gelonghui reported that ZHONG JI LS (00767.HK) announced that on April 1, 2025, its wholly-owned subsidiary Shenzhen ZHONG JI LS Co., Ltd. (Chalkis Health Industry) signed a joint venture agreement with Huali (Guangdong) Life Science Technology Co., Ltd. (Huali Life) to establish a joint venture company in China, which will have 51% owned by Chalkis Health Industry and 49% owned by Huali Life at the time of establishment. The joint venture company will primarily provide longevity health services in China. The initial registered capital of the joint venture company is 1,000,000 RMB, which will be contributed by Chalkis Health Industry and Huali.
Express News | Zhong Ji Longevity Science - Formation of Joint Venture With Initial Registered Capital of RMB1 Mln
ZHONG JI LS: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2024
Express News | Zhong Ji Longevity Science Group Ltd - Expects Net Loss of HK$32M-HK$35M for FY24
ZHONG JI LS: PROFIT WARNING
ZHONG JI LS (00767.HK) will hold a Board of Directors meeting on March 28 to approve the annual performance.
Gelonghui, March 18th丨ZHONG JI LS (00767.HK) announced that the company will hold a Board of Directors meeting on March 28, 2025, to approve the announcement of the annual performance for the year ending December 31, 2024, and to consider the proposal for the distribution of the final dividend (if any).